A review on biosimilar infliximab, CT-P13, in the treatment of inflammatory bowel disease

Farkas, K; Molnar, T

Molnar, T (reprint author), Univ Szeged, Dept Med 1, Szeged, Hungary.

IMMUNOTHERAPY, 2018; 10 (2): 107

Abstract

The introduction of biological agents has led to significant changes in the treatment of inflammatory bowel disease (IBD). The relatively high price o......

Full Text Link